PhD Student
UCL Cancer Institute, United Kingdom
Bethan Hudson-Lund, PhD student at University College London Cancer Institute.
Bethan graduated from the University of Durham with a BSc in Biological Sciences before working as Assistant Scientist at a CRO developing drug-efficacy and immunogenicity risk assessment bioassays. Her PhD research focuses on computational analysis of genomic and transcriptomic variants in myeloma and aims to explore potential immune consequences, including antigenicity and immunoediting. She is also a visiting student at the University of Oxford and in collaboration with Achilles Therapeutics, funded by the MRC DTP iCASE programme.